1. Home
  2. INBS vs GNPX Comparison

INBS vs GNPX Comparison

Compare INBS & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBS
  • GNPX
  • Stock Information
  • Founded
  • INBS 2016
  • GNPX 2009
  • Country
  • INBS United States
  • GNPX United States
  • Employees
  • INBS N/A
  • GNPX N/A
  • Industry
  • INBS Medical Specialities
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INBS Health Care
  • GNPX Health Care
  • Exchange
  • INBS Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • INBS 8.7M
  • GNPX 7.0M
  • IPO Year
  • INBS N/A
  • GNPX 2018
  • Fundamental
  • Price
  • INBS $1.24
  • GNPX $0.24
  • Analyst Decision
  • INBS
  • GNPX Strong Buy
  • Analyst Count
  • INBS 0
  • GNPX 1
  • Target Price
  • INBS N/A
  • GNPX $10.00
  • AVG Volume (30 Days)
  • INBS 113.6K
  • GNPX 2.8M
  • Earning Date
  • INBS 05-13-2025
  • GNPX 05-12-2025
  • Dividend Yield
  • INBS N/A
  • GNPX N/A
  • EPS Growth
  • INBS N/A
  • GNPX N/A
  • EPS
  • INBS N/A
  • GNPX N/A
  • Revenue
  • INBS $2,936,472.00
  • GNPX N/A
  • Revenue This Year
  • INBS $280.88
  • GNPX N/A
  • Revenue Next Year
  • INBS $126.26
  • GNPX N/A
  • P/E Ratio
  • INBS N/A
  • GNPX N/A
  • Revenue Growth
  • INBS 3.87
  • GNPX N/A
  • 52 Week Low
  • INBS $1.00
  • GNPX $0.22
  • 52 Week High
  • INBS $3.04
  • GNPX $4.09
  • Technical
  • Relative Strength Index (RSI)
  • INBS 43.94
  • GNPX 40.63
  • Support Level
  • INBS $1.16
  • GNPX $0.22
  • Resistance Level
  • INBS $1.43
  • GNPX $0.36
  • Average True Range (ATR)
  • INBS 0.10
  • GNPX 0.03
  • MACD
  • INBS 0.02
  • GNPX -0.00
  • Stochastic Oscillator
  • INBS 42.42
  • GNPX 14.93

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: